Skip to main content

Table 1 Demographic and clinical data of patients with P. vivax infection included in the study.

From: Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010

 

Number (%) or median (95%CI)

Patient characteristics:

Number included

130 (64 females, 66 males) (17 Thais, 113 Burmeses)

Age [years: median (95% CI)]

22 (15-55)

Admission parasitaemia [/μl: median (95% CI)]

4,898 (1,206-29,480)

Clinical outcome:

Number (%) completed 42 days follow-up

130 (100)

Number (%) cured by day 42

130 (100)

PCT [h: median (95% CI)]

30 (18-36)

FCT [h: median (95% CI)]

24 (12-42)

  1. Data are presented as number (%) or median (95% CI).
  2. PCT (parasite clearance time): The time taken for the parasite count to fall below the level of microscopic detection
  3. FCT (fever clearance time): the time taken for the temperature to return to normal, i.e., <37.3°C and remain so for at least 24 hours